PHARMAFLOR
ActiveSummary
PHARMAFLOR has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €293,388 and a net result of €129,524. Equity is growing by about 47% per year across the filed financial years. Its solvency ranks better than 49% of 12,737 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
18-08
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format · 18 days late
2025
31-12
Financial
Highest result from 2018 to 2025net €129,524 ▲48.4%
Operating result €190,969, net result €129,524, both a record.
31-12
Financial
Equity above €200,000equity €293,388 ▲79%
A profit in every financial year since 2018 builds equity to €293,388.
18-08
NBB filing
Annual accounts filed
financial year 2024 · full format · 18 days late
26-02
Gazette deed
Appointment: Catherine DELVAUX (director)Shareholding · Capital · Amendment of the articles15 facts ▸
Gazette deed
Appointment: Catherine DELVAUX (director)
Shareholding · Capital · Amendment of the articles15 facts ▸
- General meeting, 20-02-2025
- Shareholding, “parts sociales”, 1000 (deed in French)
- Other provision, “présidente, bureau de séance” (deed in French)
- Other provision, “mise en conformité des statuts suite à entrée en vigueur du Code des Sociétés et des Associations-adoption forme SRL, Mandat” (deed in French)
- Capital (2 times)
- Other provision, “chaque part sociale donne droit à une voix, validité de l'assemblée” (deed in French)
- Other provision, “délibération, aborde ordre du jour et prend résolutions suivantes” (deed in French)
- Amendment of the articles
- Capital conversion, “suppression immédiate compte de capitaux propres statutairement indisponible, fonds disponibles pour distribution” (deed in French)
- Legal-form conversion, “Société à Responsabilité Limitée” (deed in French)
- Other provision, “dispense lecture rapport, rapport organe de gestion sur modification objet” (deed in French)
- Other provision, “réception rapport modification objet, rapport organe de gestion article 5:101” (deed in French)
- +3 further facts in this act
2024
31-12
Financial
Equity above €150,000equity €163,864 ▲114%
A profit in every financial year since 2018 builds equity to €163,864.
06-08
NBB filing
Annual accounts filed
financial year 2023 · full format · 6 days late
2023
20-06
NBB filing
Annual accounts filed
financial year 2022 · full format
2022
29-07
NBB filing
Annual accounts filed
financial year 2021 · full format
2021
27-07
NBB filing
Annual accounts filed
financial year 2020 · full format
2020
04-08
NBB filing
Annual accounts filed
financial year 2019 · full format · 4 days late
2019
23-08
NBB filing
Annual accounts filed
financial year 2018 · full format · 23 days late
2018
28-08
NBB filing
Annual accounts filed
financial year 2017 · full format · 28 days late
2017
23-08
NBB filing
Annual accounts filed
financial year 2016 · full format · 23 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 19 annual accounts filed, the latest 10 are here; all 19 are under Financials.
1 of 2 deeds read
About the unread acts
Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.